UK Companies House feature
SEKISUI DIAGNOSTICS (UK) LIMITED
Profile
- Company number
- 07457131
- Status
- Active
- Incorporation
- 2010-12-01
- Last accounts made up
- 2025-03-31
- Account category
- FULL
- Primary SIC
- 32500
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101 Reduced Disclosure Framework
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Under both the base case and the severe but plausible downside scenario, the forecasts indicate that the company will have sufficient liquidity to continue to settle its liabilities as they fall due for a period of at least 12 months from the date of approval of the financial statements. Consequently, the Directors believe it is appropriate to continue to prepare the financial statements on a going concern basis.”
Subsidiaries
- Sekisui Diagnostics GmbH · 100% held · Germany · sales and distribution of chemical reagents
Significant events
- “The loss for the year after taxation amounted to £4,585,776 (year ended 31 March 2024 loss of £4,070,916). The results reflect a combination of reduction in requirements of some Diagnostics Enzyme products and demand growth from some Diagnostic Enzyme customers which is impacting mix and profitability of the Enzyme business, which is being addressed through pricing and cost control measures.”
- “We are part way through a budgeted significant investment (£20M) to enable us to grow our Biopharma CDMO (Contract Development and Manufacturing Organisation) business. R&D and QC labs have been completed and are occupied and the main part of the investment (£18.5M) in a Bio Pharma production facility is partially completed and expected to be commissioned, validated and operational in FY26.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DIGBY, Louise Clare, Mrs. | Director | 2023-12-31 | Oct 1974 | British |
| NAGURA, Masaki | Director | 2025-10-31 | Aug 1965 | Japanese |
| SCHRUENDER, Robert Timothy | Director | 2015-03-01 | Dec 1966 | American |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FUKUDA, Mutsumi | Director | 2011-01-14 | 2014-03-31 |
| KON, Tetsuaki | Director | 2014-03-31 | 2015-03-01 |
| MANABE, Mitsuhisa | Director | 2011-01-14 | 2014-03-31 |
| NEGAMA, Tsutomu | Director | 2020-09-30 | 2025-10-31 |
| STOCKBURN, William Albert, Dr | Director | 2018-06-12 | 2023-12-31 |
| TAGASHIRA, Hideo | Director | 2014-03-31 | 2015-03-01 |
| TAKAHASHI, Eiichi | Director | 2014-10-01 | 2020-09-30 |
| TSUCHIHASHI, Goichi | Director | 2015-03-01 | 2018-06-12 |
| YOSHIDA, Katsuhiro | Director | 2010-12-01 | 2011-02-14 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Sekisui Chemical Co., Ltd. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 61 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-11-28 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-11-04 | AP01 | officers | appoint person director company with name date |
| 2025-11-04 | TM01 | officers | termination director company with name termination date |
| 2025-10-17 | AA | accounts | accounts with accounts type full |
| 2025-07-31 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2025-07-31 | PSC09 | persons-with-significant-control | withdrawal of a person with significant control statement |
| 2024-11-20 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-11-14 | AA | accounts | accounts with accounts type full |
| 2024-01-10 | AP01 | officers | appoint person director company with name date |
| 2024-01-10 | TM01 | officers | termination director company with name termination date |
| 2023-12-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-11-13 | AA | accounts | accounts with accounts type full |
| 2022-12-12 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-08-24 | AA | accounts | accounts with accounts type full |
| 2021-12-20 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-11-29 | AA | accounts | accounts with accounts type full |
| 2021-03-23 | AA | accounts | accounts with accounts type full |
| 2020-12-23 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-10-01 | AP01 | officers | appoint person director company with name date |
| 2020-09-30 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Composite activity score · components 0–100 · reference 2026-05-10
37.5
COLD
/ 100
- Filings velocity 50
- Capital events 0
- Officer churn 50
- Headcount trajectory 50
- Accounts trajectory 50
- 6 filing(s) in last 12 months
- 1 appointed, 1 resigned (12mo)